I. Cavattoni

发表

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML.

B. Falini, A. Bosi, A. Cortelezzi, 2019, Blood advances.

Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.

G. Lucchini, S. Galimberti, A. Balduzzi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Title: Achieving a Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long Term Outcome

Margherita, Arianna, F. Mannelli, 2016 .

Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00.

A. Levis, F. Mannelli, G. Rossi, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.

R. Valgardsdottir, S. Napolitano, A. Balduzzi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study

G. Rossi, G. Rossi, L. Pagani, 2011, Bone Marrow Transplantation.

Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation

N. Kröger, A. Zander, F. Ayuk, 2010, Leukemia & lymphoma.

Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome.

F. Mannelli, A. Cortelezzi, F. Ciceri, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease

M. Fumagalli, F. Mannelli, A. Bosi, 2012, Haematologica.

‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

S. Santarone, L. Facchini, D. Baronciani, 2018, Bone Marrow Transplantation.

Bendamustine salvage for the treatment of relapsed Hodgkin’s lymphoma after allogeneic bone marrow transplantation

M. Farsad, M. Mian, S. Deola, 2012, Annals of Hematology.

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.

P. Chiusolo, A. Nagler, A. Bosi, 2015, The Lancet. Oncology.

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)

A. Ferrario, M. De Gobbi, M. Marcatti, 2021, Bone Marrow Transplantation.

Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.

A. Levis, M. Boccadoro, A. Risitano, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect

D. Baronciani, F. Ciceri, F. Bonifazi, 2012, Leukemia.

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07

M. Fumagalli, A. Cortelezzi, F. Ciceri, 2020, Blood Cancer Journal.

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation

P. Chiusolo, A. Signori, T. Lamparelli, 2021, Blood advances.

Evidence for CD19B–CD8T cell interactions in blood and tissues from patients with GvHD

F. Marincola, S. Rutella, E. Wang, 2016, Bone Marrow Transplantation.

Evidence for CD 19 B – CD 8 T cell interactions in blood and tissues from patients with GvHD Bone

S. Rutella, E. Wang, F. Marincola, 2016 .

Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

R. Fanin, M. Isola, F. Ciceri, 2020, Frontiers in Oncology.